Status:
UNKNOWN
Nutrition and Lifestyle Study Cohort of Gastric Cancer in China
Lead Sponsor:
State Key Laboratory of Cancer Biology
Collaborating Sponsors:
Tang-Du Hospital
Tianjin Union Medical Center
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
China has the largest gastric cancer patients population all over the world. Recent reports concluded nutrition status and lifestyle factors were associated with gastric cancer risk, however, the infl...
Detailed Description
Background - Gastric cancer incidence is increasing at an alarming rate in China. Recent studies reported that nutrition status and lifestyle factors such as dietary pattern, obesity, physical activit...
Eligibility Criteria
Inclusion
- Patient must have a histologically proven adenocarcinoma of gastric cancer.
- Patients must have a performance status of 0,1, or 2 by the Southwest Oncology Group criteria.
- Patients must have recovered from any effects of surgery.
- Evaluable disease must be present outside radiation field. At least 3 weeks must have elapsed after discontinuation of radiation therapy.
- Patients must provide a signed consent to participate in the study.
- Patients must complete all questionnaires.
Exclusion
- Patients with a proven history of peptic ulcer disease or gastroesophageal reflux.
- History of other malignancy, except for cancers that have been treated with a curative intent and patient is without evidence of active disease.
- Unresolved bacterial infection requiring treatment with antibiotics.
- Pregnant or lactating women may not participate in the study.
- Patients known to have HIV-1 virus infection because of the undetermined effect of this chemotherapy regimen in patients with HIV-1 and the potential for serious interaction with anti-HIV medications..
- Other serious concurrent infection
- Clinically significant cardiac disease not well controlled with medication (e.g. congestive heart failure, symptomatic coronary artery disease and cardiac arrhythmias) or myocardial infarction within the last 12 months.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT02216955
Start Date
January 1 2009
Last Update
February 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State Key laboratory of Cancer Biology
Xi'an, Shaanxi, China, 710032